App-Quantinova.ai

The Cumulative Burden of Potentially Modifiable Cardiac Risk Factors is Modestly Associated With a Perceived Need to Improve Physical Health: A Population-Based Study of Canadian Adults

Yue Chen - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Myocardial infarction

N/A

Outcomes of Heart Failure (HF) Patients Admitted to the Intensive Care Unit (ICU): Impact of Early or Late ICU Admission

Heather J Ross - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

N/A

Neighborhood Walkability Was Not Associated With Odds of Hypertension

Gillian L Booth - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Hypertension

N/A

Increased Cost of Cardiac Surgery in Frail Compared to Non-frail Older Adults

Melissa Bendayan - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

Clinical Outcomes of Plavix and Generic Clopidogrel for Patients With Hospitalized With an Acute Coronary Syndrome

Jack Tu - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Transient Ischemic Attack

Clopidogrel bisulfate

HSP27 and Anti-HSP27 Autoantibodies: Novel CAD Biomarkers That Non-Invasively Stratified a Medically Underserviced Population

Chunhua Shi - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Validation of the Adult Hypertrophic Cardiomyopathy Sudden Death Risk Calculator in a Pediatric Population

Julia Jeon - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Hypertrophic cardiomyopathy

N/A

Chest Pain Clinic Assessment After Emergency Department Discharge With Low Risk Chest Pain is Associated With a Reduction in Hospitalizations and Emergency Re-Visitation

Yunqi Ji - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Angina

Mofezolac

Trends and Outcomes of Outpatient Management of Pulmonary Embolism in a Real World Setting

Janie Coulombe - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Deep vein thrombosis

N/A

Electrocardiographic Assessment of Brugada Syndrome in Children

Jason Klemensberg - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Brugada syndrome

Procainamide

Elabela, a Novel Apj-receptor Agonist, Improves Fluid Homeostasis and Reduces Cardio-renal Dysfunction During Acute Heart Failure (AHF)

Xavier Sainsily - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Myocardial Dysfunction

N/A

Elevated Inflammatory Plasma Biomarkers in Patients With Anderson-Fabry Disease: A Critical Link to Heart Failure With Preserved Ejection Fraction

Brendan N Putko - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart failure with preserved ejection fraction

ILS-969

The Clinical Characteristics and Prognosis of Patients With Anthracycline-Induced Cardiomyopathy

Vince Siu - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Hematological malignancies

N/A

Hospitalization for De Novo versus Worsening Chronic Heart Failure: Insights From the ASCEND-HF Trial

Adrian F Hernandez - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Congestive heart failure

Nesiritide

Safety of Disopyramide in Patients With Hypertrophic Cardiomyopathy - Is Initation of Therapy in Hospital Really Required?

Fourey Dana - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Left ventricular outflow tract obstruction

disopyramide

Human Epididymis Protein 4 (HE4) and Outcome in Low-Flow, Low-Gradient Aortic Stenosis

Abdellaziz Dahou - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Pseudo-severe aortic stenosis

N/A

Left Ventricular Flow Dynamics in the Presence of Severe Mitral Annular Calcification - An In Vitro Study

Batoul El Sayegh - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Mitral annular calcification

N/A

Right Ventricular Stemi as a Cause of Death in Idiopathic Pulmonary Arterial Hypertension

Barry Burstein - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Pulmonary arterial hypertension

Epoprostenol

Novel Ryanodine Receptor Mutation Associated With Hypertrophic Cardiomyopathy Induces Cardiac Remodeling and Arrhythmia in Mice

Carmen R Valdivia - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertrophic cardiomyopathy

Isoproterenol

Stimulation of Soluble Guanylate Cyclase Activity With Riociguat Promotes Angiogenesis and Improves Neovascularization After Hindlimb Ischemia

Sylvie Dussault - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

Riociguat

Filters

28841 Abstracts